LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 17 filers reported holding LAVA THERAPEUTICS NV in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,327,312 | $14,640,000 | 0.62% |
| Redmile Group, LLC | 2,816,196 | $12,391,000 | 0.39% |
| Nicholas Investment Partners, LP | 523,920 | $2,305,000 | 0.16% |
| DAFNA Capital Management LLC | 139,332 | $613,000 | 0.16% |
| Nantahala Capital Management | 334,164 | $1,470,000 | 0.06% |
| Alpha Wave Global, LP | 121,193 | $533,000 | 0.05% |
| Artal Group S.A. | 200,000 | $880,000 | 0.04% |
| AXA S.A. | 463,772 | $2,040,298 | 0.00% |
| Point72 Asset Management, L.P. | 116,981 | $515,000 | 0.00% |
| TSFG, LLC | 400 | $2,000 | 0.00% |